Relative to the share price of April 20, the dividend yield reaches 0.6%, per calculations by Ziarul Financiar (ZF) based on stock market reports.
The registration date is September 3 and the payment date is September 20.
The company ended 2020 with sales income of RON340.4 million, down 12.6% from 2019, and a net profit of RON26.4 million, down 14.4% from 2019, per ZF calculations based on the company’s annual report.
The company has a market capitalization of RON355.8 million and its shares have been trading up 7.4% amid deals worth RON19.2 million, per stock market data.
Antibiotice Iasi is 53% owned by the Romanian state and regional investment fund SIF Oltenia owns 19%.